Association of ERCC1 protein expression to platinum resistance in epithelial ovarian cancer

被引:0
|
作者
Steffensen, K. D. [1 ]
Waldstrom, M. [1 ]
Jakobsen, A. [1 ]
机构
[1] Vejle Hosp, Vejle, Denmark
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5530
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Association of ERCC1 protein expression to platinum resistance in epithelial ovarian cancer
    Waldstrom, M.
    Dahl, Steffensen K.
    Jacobsen, A.
    VIRCHOWS ARCHIV, 2009, 455 : 286 - 286
  • [2] The Relationship of Platinum Resistance and ERCC1 Protein Expression in Epithelial Ovarian Cancer
    Steffensen, Karina Dahl
    Waldstrom, Marianne
    Jakobsen, Anders
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 820 - 825
  • [3] High ERCC1 expression is associated with platinum-resistance, but not survival in patients with epithelial ovarian cancer
    Du, Pei
    Wang, Yifeng
    Chen, Liquan
    Gan, Yaping
    Wu, Qinian
    ONCOLOGY LETTERS, 2016, 12 (02) : 857 - 862
  • [4] ERCC1 Expression as a Predictor of Resistance to Platinum-based Chemotherapy in Primary Ovarian Cancer
    Muallem, Mustafa Zelal
    Braicu, Ioana
    Nassir, Mani
    Richter, Rolf
    Sehouli, Jalid
    Arsenic, Ruza
    ANTICANCER RESEARCH, 2014, 34 (1A) : 393 - 399
  • [5] Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: The prediction value of ERCC1 and Tau expression
    Steffensen, Karina Dahl
    Smoter, Marta
    Waldstrom, Marianne
    Grala, Bartlomiej
    Bodnar, Lubomir
    Stec, Rafal
    Szczylik, Cezary
    Jakobsen, Anders
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (05) : 1736 - 1744
  • [6] Increased ERCC1 Protein Expression Is Associated with Suboptimal Debulking in Advanced Epithelial Ovarian Cancer
    Lin, Feili
    Lin, Kaiqing
    Xie, Xing
    Zhou, Caiyun
    ANTICANCER RESEARCH, 2010, 30 (06) : 2447 - 2452
  • [7] ERCC1 expression and platinum chemosensitivity in patients with ovarian cancer: A meta-analysis
    Zhang, Chunjie
    Gao, Shan
    Hou, Jingwen
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2020, 35 (04): : 12 - 19
  • [8] Multimodality evaluation of excision repair cross-complementation 1 (ERCC1) expression as a predictive biomarker for platinum resistance in epithelial ovarian cancer (EOC).
    Michie, C. O.
    Song, L.
    Faratian, D.
    Orr, J.
    Rye, T.
    Clark, J.
    Bartlett, J. M.
    Harrison, D. J.
    Melton, D.
    Williams, A.
    Gourley, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy
    Li Yan
    Yang Shu-Ying
    Kang Shan
    Yip, Benjamin H. K.
    Zhou Rong-Miao
    Wang Na
    Sun Hai-Yan
    PHARMACOGENOMICS, 2012, 13 (04) : 419 - 427
  • [10] The evaluation of BRCA1 and ERCC1 expression as predictors of platinum response in ovarian cancer
    Weberpals, J. I.
    Clark-Knowles, K.
    O'Brien, A.
    Antoniouk, O.
    Garbuio, K.
    Dimitroulakos, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)